NCT00235469View on ClinicalTrials.gov

A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

496

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Diabetic Neuropathy
Interventions
DRUG

SPM 927

Trial Locations (1)

Unknown

Schwarz, RTP

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY